We performed a co‐immunofluorescence assay by combining GBM (CD105–, CD44+ and CD45+) and MSLC (CD105+, CD44+ and CD45–) to confirm the expressions of CD40L and CD40 in GBM cells and MSLCs in the in vivo mouse tissue sample. The gene discussed is CD44; the disease is glioblastoma.